All In Biotech

Free tool

FAERS Monitor: Aponvie

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 216457 or its brand name (Aponvie, Aprepitant). Reports on generic versions are filed under their own applications.

Reports

7,377

Serious

7,064

96% of reports

Hospitalization

4,447

Death reported

1,464

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue1,287
  • nausea1,105
  • pyrexia921
  • off label use872
  • alopecia823
  • dyspnoea807
  • diarrhoea770
  • rash764
  • vomiting702
  • hypersensitivity701
  • pain690
  • infusion related reaction689
  • decreased appetite684
  • stomatitis663
  • pruritus662

Reports by year received

View as table
YearReports
20047
200515
200628
200724
200829
200948
201066
2011105
2012141
2013169
2014160
2015228
2016393
2017164
2018340
2019413
2020488
2021662
2022634
2023748
20241,026
2025889
2026600

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,046,782 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
stomatitisSignal66331.529.319,391
infusion related reactionSignal68929.927.919,103
alopeciaSignal82312.011.28,326
hypersensitivitySignal70110.810.16,259
decreased appetiteSignal6848.47.84,500
pyrexiaSignal9217.67.25,352
rashSignal7645.04.72,491
pruritusSignal6624.94.62,097
fatigueSignal1,2874.74.53,907
vomitingSignal7024.34.01,787
dyspnoeaSignal8074.13.81,914
nauseaSignal1,1054.03.82,560
diarrhoeaSignal7703.43.21,345
painSignal6903.23.01,075
off label useSignal8722.82.71,083

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.